IP Verse

Maiwald patent opposition analysis

Get complete Patent Opposition Report for Maiwald

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Maiwald

Explore patent oppositions filed by Maiwald against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3270966	Combination Of Hdac Inhibitor And Anti-Pd-1 Antibody For Treatment Of Cancer	SYNDAX PHARMACEUTICALS	Jan 31, 2025
EP3582814	Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal Manifestations	ARENA PHARMACEUTICALS	Jan 31, 2025
EP3215166	Altering Gene Expression In Cart Cells And Uses Thereof	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA	Jan 23, 2025
EP3090730	Novel Pharmaceutical Composition	NOVARTIS	Jan 10, 2025
EP3191120	Use Of Il-17 Antagonists To Inhibit The Progression Of Structural Damage In Psoriatic Arthritis Patients	NOVARTIS	Jan 10, 2025
EP3823671	Inhibition Of Prc2 Subunits To Treat Eye Disorders	FONDATION ASILE DES AVEUGLES	Nov 7, 2024
EP3474820	Glp-1 Compositions And Uses Thereof	NOVO NORDISK	Nov 6, 2024
EP3551687	Method For Producing A Stabilizer Composition, And Stabilizer Composition Produced Using Said Method	AKDENIZ CHEMSON ADDITIVES	Oct 23, 2024
EP2395968	Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient	BOEHRINGER INGELHEIM	Oct 17, 2024
EP3791896	Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer	ASTELLAS PHARMA	Oct 8, 2024

Top competitors of Maiwald

NOVARTIS

AMGEN

OTSUKA PHARMACEUTICAL